Yoav Shaked
Board Member at AIVF- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
AIVF
-
Israel
-
Software Development
-
1 - 100 Employee
-
Board Member
-
Dec 2021 - Present
Israel
-
-
-
Entail AI
-
Israel
-
Technology, Information and Internet
-
1 - 100 Employee
-
Board Observer & Investor
-
Sep 2021 - Present
USA
-
-
-
AskIris
-
Media Production
-
1 - 100 Employee
-
Co-Founder
-
Sep 2021 - Present
USA
-
-
-
DarioHealth
-
United States
-
Wellness and Fitness Services
-
200 - 300 Employee
-
Board Chairman
-
Jul 2018 - Present
Israel
-
-
-
Sequoia Capital
-
United States
-
Venture Capital and Private Equity Principals
-
200 - 300 Employee
-
Partner
-
Sep 2011 - Present
Herzeliya, Israel
-
-
-
Orasis Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Board Member
-
Jan 2016 - Present
-
-
-
B-Lite (G&G Biotechnology), Now Part of POLYTECH
-
Netherlands
-
Medical Equipment Manufacturing
-
1 - 100 Employee
-
Board Member
-
Aug 2015 - Present
-
-
-
-
Chairman Of The Board Vibrant Gastro
-
Sep 2014 - Present
Israel
-
-
-
MEDPOINT LTD
-
United Kingdom
-
Hospitals and Health Care
-
1 - 100 Employee
-
Co-Founder
-
Jan 2005 - Present
Netanya Area, Israel
-
-
-
Endospan Ltd.
-
Israel
-
Medical Device
-
1 - 100 Employee
-
Board Member
-
Apr 2013 - Present
Israel
-
-
-
-
Director of Research At ThermopeutiX
-
2009 - Jan 2010
Assessment and identification of new business opportunities in the area of PAD, Stroke and Cardiac arrest. Consulting services to Bard after its acquisition of YMed Inc. Helping with operation, product development and continuing transforming the acquired technology into sales.
-
-
-
-
Founder & CEO at Y-Med Inc.
-
May 2004 - Nov 2009
San Diego, CA USA YMed, Inc. (subsidiary of C.R. Bard) was an emerging growth medical device company developing next generation products for endovascular applications. YMed focused on the successful commercialization of a novel Focused Force Balloon Angioplasty for use in peripheral arterial vasculature.
-
-
-
-
VP & COO at XTechnolohies
-
Jan 2000 - Mar 2004
Held multiple managerial and crucial responsibilities in the company from its inception as a small start-up specializing in medical biotechnologies to its final sale in March 2003 to Guidant, Corp. In particular:
-
-
Education
-
The Hebrew University of Jerusalem